, or <70mg/dl depending on risk profile.

Outcomes and Surveillance
Asymptomatic carotid stenosis
 The historically touted Asymptomatic Carotid Atherosclerosis Study (ACAS) demonstrated that patients with >60% carotid stenosis who underwent CEA benefited significantly from stroke risk reduction at 5 years (5.1% for CEA vs. 11% for optimal medical
therapy consisting of aspirin alone).
